Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Idex (IEX) Asset Writedowns and Impairment (2019 - 2025)

Idex (IEX) has disclosed Asset Writedowns and Impairment for 7 consecutive years, with $100000.0 as the latest value for Q3 2025.

  • On a quarterly basis, Asset Writedowns and Impairment changed N/A to $100000.0 in Q3 2025 year-over-year; TTM through Dec 2025 was $200000.0, a 50.0% decrease, with the full-year FY2025 number at $700000.0, up 600.0% from a year prior.
  • Asset Writedowns and Impairment was $100000.0 for Q3 2025 at Idex, roughly flat from $100000.0 in the prior quarter.
  • In the past five years, Asset Writedowns and Impairment ranged from a high of $16.8 million in Q3 2022 to a low of $100000.0 in Q1 2021.
  • A 5-year average of $2.1 million and a median of $200000.0 in 2022 define the central range for Asset Writedowns and Impairment.
  • Peak YoY movement for Asset Writedowns and Impairment: surged 2700.0% in 2022, then crashed 98.21% in 2023.
  • Idex's Asset Writedowns and Impairment stood at $600000.0 in 2021, then crashed by 33.33% to $400000.0 in 2022, then dropped by 25.0% to $300000.0 in 2023, then plummeted by 66.67% to $100000.0 in 2024, then changed by 0.0% to $100000.0 in 2025.
  • Per Business Quant, the three most recent readings for IEX's Asset Writedowns and Impairment are $100000.0 (Q3 2025), $100000.0 (Q4 2024), and $300000.0 (Q3 2023).